Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BG Thiazolidinediones
A10BG02 Rosiglitazone
D00596 Rosiglitazone maleate (JAN/USP)
USP drug classification [BR:br08302]
Blood Glucose Regulators
Antidiabetic Agents
Thiazolidinedione
Rosiglitazone
D00596 Rosiglitazone maleate (JAN/USP)
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01683 Thiazolidinedione type PPAR agonist
DG00116 Rosiglitazone
D00596 Rosiglitazone maleate
DG02044 Hypoglycemic agent
DG01683 Thiazolidinedione type PPAR agonist
DG00116 Rosiglitazone
D00596 Rosiglitazone maleate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Peroxisome proliferator-activated receptor (PPAR)
NR1C3 (PPARG)
D00596 Rosiglitazone maleate (JAN/USP)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00596
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00596
Drug groups [BR:br08330]
Antidiabetic agent
DG01685 Insulin sensitizer
DG01795 PPAR gamma agonist
DG01683 Thiazolidinedione type PPAR agonist
DG00116 Rosiglitazone
DG02044 Hypoglycemic agent
DG01683 Thiazolidinedione type PPAR agonist
DG00116 Rosiglitazone